Wells Fargo Upgrades Voyager Therapeutics (VYGR) to Overweight
Tweet
Share
E-mailGet Alerts VYGR Hot Sheet
Price: $2.87 -8.6%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Wells Fargo analyst Jim Birchenough upgraded Voyager Therapeutics (NASDAQ: VYGR) from Equal Weight to Overweight with a price target of $14.00 (from $9.00).
For an analyst ratings summary and ratings history on Voyager Therapeutics click here. For more ratings news on Voyager Therapeutics click here.
Shares of Voyager Therapeutics closed at $8.44 yesterday.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- IGO Limited (IGO.AU) (IPGDF) PT Lowered to AUD6.90 at RBC Capital
- Jefferies Upgrades Valeo SA (FR:FP) (VLEEY) to Buy
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
